Call for Abstract

Abstract Submission

Abstract submission is now closed.
Thanks to those of you who have submitted abstracts.

Important Announcement

    1. All submissions must include a 320-word abstract and a 200-word novelty of your research written in English.
    2. All presenters for both categories must submit an electronic poster (CyPos) written in English by the due date.
    3. Submitted CyPos (electronic poster) will be open for viewing from April 10 to April 30, 2014for registered participants of the JRC 2014.

Period for Abstract Submission

September 2, 2013 – 12 noon (JST) of October 28, 2013

The abstract deadline is extend to the midday of October 29

Contact

For any information about abstract submission, please contact by e-mail*.

Medical Tribune, Inc.
Itarian Cultural Institute Bldg.
2-1-30, Kudan Minami, Chiyoda-ku, Tokyo 102-0074, Japan
*E-mail: jsrt-mt@medical-tribune.co.jp

Presentation Categories

ORAL PRESENTATION

    The type is an accepted paper by the program committee of the JSRT, and includes both of the followings.
  • submission of an Electronic Poster (CyPos) before the due date, and
  • 7 minutes presentation followed by 3 minutes for questions and answer discussion at the conference room.

Room, a date, and a time for oral presentation will be notified by letter or email of the acceptance.
We encourage you to take full advantage of visual aids through the use of computer monitor projection.

Note:
  • The program committee of the JSRT will decide acceptance or rejection and the category of your presentation based on your abstract (max. 320 words) that is submitted by October 28, 2013. All decisions are final.
  • Withdrawal after January 25, 2014 or no-show to the conference in Yokohama is subject to penalty of acceptance for future meetings, and may not be published in the proceedings and the meeting program of the 70th annual meeting of the JSRT.

Submission Details

Please note the following

The Latest Changes

  • Change in the Period for Abstract Submission ;
    The online abstract submission will open  September 2, 2013,
    and will close at 12 noon (JST) Monday, October 28, 2013.
  • Refurbishment of Presentation Categories ;
    See Presentation Categories for more details on.
  • You cannot download CyPos (electronic poster) file that you are browsing.
  • Submitted CyPos will be open for viewing from April 10 to April 30, 2014 for registered participants of the JRC 2014.
  • All authors are required to disclose any conflicts of interest prior to the submission of any papers in the subject matter of which any company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
    Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
  • You are the presenting author on an abstract that was accepted and you cannot attend the conference. Instead of withdrawing, please select a co-author to present the abstract in your place. You must choose at least one substitute presenter for you.

Presenting Author

Name

      The author’s name should be written completely, avoid any abbreviation.
    First name and middle initial followed by last/surname.

Membership No.

Members
    Please enter your 7-digit membership number which starts with “00”.
Non-members (Including Supporting members) , Now applying for membership
    Please leave the text box blank.

Institution/Affiliation

      Please limit your institution and affiliation less than 33 words.
      The institution and affiliation of the presenting author should be written completely, avoid any abbreviation.
    (ex.) The Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan

Address

      The presenting author’s address should be written completely, avoid any abbreviation.
    Country, Address, Postal/Zip Code, Telephone Number, Extension(if any).

E-mail address

A confirmation email is sent to the registered email address automatically when you complete submission.

If you do not receive a confirmation email from us within 24 hours,
please contact the Medical Tribune Inc.

Co-author(s)

Please add in a co-author if necessary (6 or less).

Membership No.

Members
    Please enter your 7-digit membership number which starts with “00”.
Non-members (Including Supporting members) , Now applying for membership
    Please leave the text box blank.

Institution/Affiliation

      In the case that the co-authors’ institution is different from the presenting author’s, enter the names of those institutions in the box.
      Then input other authors’ names and select the numbers which indicate institutions you list in the box.
    Please limit co-author’s institution and affiliation less than 33 words.

Alternative Presenter

      In case the registered presenter will not be able to attend the meeting, one of co-author(s) is required to be a presenter instead.
      Please select at least one of co-author(s) as the additional presenter.
    Withdrawal after January 25, 2014 or no-show to the conference in Yokohama is subject to penalty applied to acceptance for future meetings, and your content may not be published in the proceedings and the meeting program of the 70th Annual Scientific Congress of the JSRT.

Research Details

Research Category

Please select at least one research category from the list shown in each space. If you selected two or more categories, your abstract will be  reviewed by 1st category.

Title of Abstract

(ex.)Molecular mechanism of cardiac hypertrophy induced by hypertension Please limit your title to less than 30 words.

Do NOT include company name(s), brand name(s), and specific name(s) particularly related to a company.

You may NOT list your titles as a series, such as 1st report, 2nd report.

Avoid using abbreviations except “Examples of abbreviations acceptable for the paper title” below.

Examples of abbreviations acceptable for the paper title 

Abbreviations which are not included in the PDF document as of October 20, 2012 is must be changed to an acceptable expression or described in the long form.

Abstract Body and A Novelty of Research Statement

    Type your abstract in the box below. You may paste text processed off-line into the box. Follow the instructions below for special characters. If you want to include symbols and Greek Letters, type the respective code indicated in the tables at the position where you want to place it. Or copy the code and paste it in the position. If you want to use superscripts, subscripts, italics, bold, or underlines, follow the instructions below.

Symbols

(ex) p&lt;0.05 will be displayed as p<0.05.

You Type &lt; &gt; &amp; &quot; &deg; &plusmn; &times;
Display < > & ° ± ×

Greek Letters

(ex) &beta;-blocker will be displayed as β-blocker.

You Type &alpha; &beta; &gamma; &delta; &epsilon; &zeta;
Display α β γ δ ε ζ
 
You Type &eta; &theta; &iota; &kappa; &lambda; &mu;
Display η θ ι κ λ μ
 
You Type &nu; &xi; &omicron; &pi; &rho; &sigma;
Display ν ξ ο π ρ σ
 
You Type &tau; &upsilon; &phi; &chi; &psi; &omega;
Display τ υ φ χ ψ ω

Text-Decoration

Superscripts

Enclose the text between <sup> and </sup>.
For example, Na<sup>+</sup> will be displayed as Na+.

Subscripts

Enclose the text between <sub> and </sub>.
For example, H<sub>2</sub>O will be displayed as H2O.

Break

If you want to start a new line, put <br /> in the front of the sentence.

Italics

Enclose the text between <i> and </i>.
For example,<i>c-fos</i> will be displayed as c-fos.

Underlines

Enclose the text between <u> and </u>.
For example,<u>directly</u> will be displayed as directly.

Bold

Enclose the text between <b> and </b>.
For example,<b>accent</b> will be displayed as accent.

Abstract

Abstract body is limited to 320 words.

Do NOT enter the title in the body of the abstract.
Do NOT put your name and affiliation in the body of the abstract.
Do NOT use abbreviations without spell outs.
Abstracts must describe the presentation’s Purpose, Material and Methods, and Results.

A Novelty of Research Statement

A Novelty of Research Statement is limited to 200 words.

Do NOT enter the title in the novelty of research statement.
Do NOT put your name and affiliation in the novelty of research statement.
Do NOT use abbreviations without spell outs.

Keyword

      Please choose up to 5 keywords.
      keyword1 is required.
      If you cannot find a suitable word on the list, please enter a keyword in the box “Others” below.
    However, keyword1 and keyword2 are not able to accept other keywords.

Questionnaire about research ethics

The research content must conform to bioethics. If necessary, please receive approval from the internal review board for morality.

If you selected ” B: This study is NOT approved by the IRB. “, please select one of the following that applies to you.

Conflict of Interest

        All authors are required to disclose any conflicts of interest prior to the submission of any papers in the subject matter of which any company, public agency, or organization has a financial interest (refer to Article 10 of Code of Ethics of the JSRT).
      Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.
    Please respond to the following questions.

Password

      Create and type your View/Update Password.
      Password is case sensitive and must be between 6 and 8 character long.
    This password is necessary for you to view or edit your abstract.

Notification of Abstract Acceptance

      A confirmation email is sent to the registered email address automatically when you complete submission.
      All abstracts submitted for the 69th Annual Scientific Congress of the JSRT are subject to peer review within the program committee after the abstract submission deadline.
    The Committee’s decision will be sent to you by e-mail.

Q&A

On-line Abstract Submission System FAQ (For Contributors)

Contact (Online Registration Inquires)

For any information about abstract submission, please contact by e-mail*.

Medical Tribune, Inc.
Itarian Cultural Institute Bldg.
2-1-30, Kudan Minami, Chiyoda-ku, Tokyo 102-0074, Japan
*E-mail:jsrt-mt@medical-tribune.co.jp